Table 2. Resource utilization and costs of patients with Parkinson's disease in Hungary.
Resource utilisation | Average yearly cost, EUR/patient/year | |||
Rate of patients with at least one occasion (%) | Mean of the quantity used in the past 12 months (n = 109) | Cost per patient (total sample) | Cost category (total sample) | |
Consultations (outpatient) | - | - | 50.9 | Direct medical cost: 2149.3 Euro/patient/year (35.7%) |
GP visit | 68 (62.3%) | 3.3 | 17.8 | |
Specialist visit | 100 (91.7%) | 4.9 | 33.1 | |
Hospital admission | 37 (33.9%) | 0.4 | 348.4 | |
Diagnostics | - | - | 42.5 | |
CT scan | 68 (62.4%) | 0.4 | 8.0 | |
MRI scan | 54 (49.5%) | 0.2 | 11.4 | |
SPECT | 17 (15.6%) | 0.04 | 17.8 | |
Laboratory tests | 67 (601.5%) | 0.8 | 0.7 | |
X-ray | 28 (25.7%) | 0.1 | 0.5 | |
Neuropsychology | 41 (37.6%) | 0.3 | 3.4 | |
Doppler | 21 (19.3%) | 0.1 | 0.4 | |
Tremor analysis | 18 (16.5%) | 0.1 | 0.2 | |
Tests of autonomic functions | 21 (19.3%) | 0.2 | 0,1 | |
Drugs (present users) | - | - | 1614.3 | |
MAO-B inhibitor | 35 (32.1%) | 179.1 | ||
Amantadine | 29 (26.6%) | 33.5 | ||
Anticholinergic drug | 4 (3.7%) | 3.9 | ||
Dopamin agonist | 50 (45.9%) | 484.7 | ||
Levodopa+decarboxylase inhibitor | 59 (54.1%) | 117.9 | ||
Levodopa+decarboxylase inhibitor+COMT inhibitor | 34 (31.2%) | - | 535.0 | |
COMT-inhibitor | 18 (16.5%) | - | 260.2 | |
Other health care services | - | - | 93.2 | |
Not reimbursed services | 19 (17.4%) | - | 57.2 | |
Ambulance | 8 (7.3%) | 0.2 | 36.0 | |
Non-medical cares | - | - | 1774.6 | Direct non-medical cost: 1774.6 EUR (29.4%) |
Transportation | 92 (84.45%) | - | 69.9 | |
Informal care | 47 (43.1%) | 12.6 hours/week | 1704.7 | |
Productivity loss | - | - | 2106.3 | Indirect cost: 2106.3 EUR (34.9%) |
Work disability pension* | 19 (17.4%) | NA | 2002.7 | |
Sick leave | 5 (4.6%) | 1.6 days/year | 75.1 | |
Part time job due to PD | 1 (0.9%) | NA | 28.5 | |
Total | NA | NA | NA | 6030.2 EUR |
For cost of drugs see also Table S2.
(N = 109; conversion €1 = 280.6 HUF);
* All of them are on disability pension due to their Parkinson's disease.